Several forms exist, but myo-inositol (MI) is the most common form in the human body and the one used in most clinical research.5 It plays an important role in insulin signaling and cellular communication, which is why it has been studied for metabolic health, PCOS, fertility, and pregnancy-related outcomes.4 6 7 Across human studies, myo-inositol is most often used in daily doses between 2,000mg and 4,000mg, typically split into two servings
If successful, these efforts could yield oral therapies for conditions ranging from osteoporosis (PTH receptor) to metabolic syndrome (glucagon/GIP receptors) that currently require injection
Track and adjust
It feels like a very minor pinch and takes less than a second to administer
Each line on a U-500 syringe represents 5 units of volume, not 1 unit
Otsuka, M., Kato, N., Ichimura, T., Abe, S., Tanaka, Y., Taniguchi, H., Hoshida, Y., Moriyama, M., Wang, Y., Shao, R., Narayan, D., Muroyama, R., Kanai, F., Kawabe, T., Isobe, T., & Omata, M